Journal article
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
Abstract
Abstractp53 mutations have profound effects on non-small-cell lung cancer (NSCLC) resistance to chemotherapeutic treatments. Mutant p53 proteins are usually expressed at high levels in tumors, where they exert oncogenic functions. Here we show that p53R175H, a hotspot p53 mutant, induces microRNA (miRNA)-128-2 expression. Mutant p53 binds to the putative promoter of miR128-2 host gene, ARPP21, determining a concomitant induction of ARPP21 mRNA …
Authors
Donzelli S; Fontemaggi G; Fazi F; Di Agostino S; Padula F; Biagioni F; Muti P; Strano S; Blandino G
Journal
Cell Death & Differentiation, Vol. 19, No. 6, pp. 1038–1048
Publisher
Springer Nature
Publication Date
6 2012
DOI
10.1038/cdd.2011.190
ISSN
1350-9047
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
ApoptosisCarcinoma, Non-Small-Cell LungCell Line, TumorCisplatinCyclin-Dependent Kinase Inhibitor p21DoxorubicinDrug Resistance, NeoplasmE2F5 Transcription FactorFluorouracilHumansLung NeoplasmsMicroRNAsPhosphoproteinsPromoter Regions, GeneticRNA, MessengerTranscription, GeneticTumor Suppressor Protein p53